{"id":1427,"date":"2025-12-22T01:07:09","date_gmt":"2025-12-22T00:07:09","guid":{"rendered":"https:\/\/fhucare2.laurent-angeli.fr\/event\/journal-club-cd-19-car-t-cell-therapy-in-multidrug-resistant-ulcerative-colitis-nejm-2025-tijc12\/"},"modified":"2025-12-26T01:55:38","modified_gmt":"2025-12-26T00:55:38","slug":"journal-club-cd-19-car-t-cell-therapy-in-multidrug-resistant-ulcerative-colitis-nejm-2025-tijc12","status":"publish","type":"post","link":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/event\/journal-club-cd-19-car-t-cell-therapy-in-multidrug-resistant-ulcerative-colitis-nejm-2025-tijc12\/","title":{"rendered":"Journal Club : CD 19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis (NEJM 2025) #TIJC12"},"content":{"rendered":"

WEBINAR Transdisciplinary Immunology Journal Club #TIJC12<\/strong><\/span><\/span><\/h4>\n


<\/strong>CD 19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis (NEJM 2025)<\/span>
With Antoine Meyer
<\/span><\/strong><\/span><\/span>Thursday, December 18, 2025 – From 2:30 PM to 3:30 PM
<\/span><\/span>Join the webinar<\/span><\/a><\/span><\/h4>\n

\"TIJC12.jpeg\"<\/a><\/p>\n

 <\/p>\n

Revoir en Replay TIJC#10
NK cells regulate CD8+ T cells via PD-1\/PD-L1 & Immunotherapy-Induced Colitis par David ZEMMOUR, MD, PhD \u2013 University of Chicago<\/p>\n<\/p>\n

Revoir en Replay TIJC#7
Anti-PD-1 amplifies co-stimulation in melanoma-infiltrating Th1-like Foxp3+ Regulatory T cells to alleviate local immunosuppression<\/strong> par Dr Mikha\u00ebl ATTIAS<\/p>\n

 <\/p>\n

Revoir en Replay TIJC#6bis
HLA class I peptide polymorphisms contribute to class II DQ\u03b20603:DQ\u03b10103 antibody specificity<\/strong> par le Dr C\u00e9dric Usureau<\/p>\n

Revoir en Replay TIJC#6
Evolution of myeloid-mediated immunotherapy resistance in prostate cancer : Lyu A & al. Nature.2025 <\/strong> par le Dr Simon COIBA, disponible ICI<\/a><\/p>\n<\/p>\n

Revoir en Replay TIJC#5
Neoantigen vaccines: a new era of precision medicine in oncology<\/strong> par le Dr Adrien MOUREN, disponible ICI<\/a><\/p>\n<\/p>\n

Revoir en Replay TIJC#4
Hallmarks of CD8+ T cell dysfunction are established within hours of tumor antigen encounter before cell division (Nat Immunol.)<\/strong> par le Dr Matthieu Roulleau Dugage, disponible ICI
<\/a><\/p>\n<\/p>\n

Revoir en Replay TIJC#3
Targeting CD206+ macrophages disrupts the establishment of a key antitumor immune axis, JExpMed. 
<\/strong>With Dr Marie ROBERT. REPLAY HERE ! <\/a><\/strong><\/p>\n<\/p>\n

Revoir en Replay TIJC#2
The type 2 cytokine Fc\u2013IL-4 revitalizes exhausted CD8+ T cells against cancer, Nature 2024. <\/strong>Par le Dr Fran\u00e7ois-Xavier Danlos, disponible ICI<\/a><\/p>\n<\/p>\n

Revoir en Replay TIJC#1
JAK Inhibitors and Cancer: Friend or Foe? <\/strong>Par le Dr Samuel Bitoun, disponible ICI<\/a><\/p><\/p>\n","protected":false},"excerpt":{"rendered":"

WEBINAR Transdisciplinary Immunology Journal Club #TIJC12 CD 19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis (NEJM 2025)With Antoine MeyerThursday, December 18, 2025 – From 2:30 PM to 3:30 PMJoin the webinar   Revoir en Replay TIJC#10NK cells regulate CD8+ T cells via PD-1\/PD-L1 & Immunotherapy-Induced Colitis par David ZEMMOUR, MD, PhD \u2013 University of Chicago Revoir en […]<\/p>\n","protected":false},"author":1,"featured_media":1428,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"event_date":"Thursday, December 18, 2025","event_location":"online webinar","event_time":"\u00a0From 2:30 PM to 3:30 PM","footnotes":""},"categories":[10],"tags":[],"class_list":["post-1427","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-event"],"_links":{"self":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts\/1427","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/comments?post=1427"}],"version-history":[{"count":3,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts\/1427\/revisions"}],"predecessor-version":[{"id":2506,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts\/1427\/revisions\/2506"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/media\/1428"}],"wp:attachment":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/media?parent=1427"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/categories?post=1427"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/tags?post=1427"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}